Defunct Company
Total Trials
4
As Lead Sponsor
2
As Collaborator
Total Enrollment
302
NCT00915187
Safety and Immunogenicity Study of Intramuscular CCS/C-adjuvanted Influenza Vaccine in Elderly
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2009
Completion: Feb 28, 2010
NCT01205087
Safety and Efficacy of Oral Administration of Anti-CD3 Monoclonal Antibody (mAb)in Patients With the Metabolic Syndrome
Role: Collaborator
Start: Sep 30, 2010
Completion: Apr 30, 2011
NCT01214538
Assessment of the Natural Antibody Response to Pneumococcal Surface Proteins During Acute Otitis Media in Children
Phase: N/A
Start: Oct 31, 2010
Completion: Jul 31, 2014
NCT01459419
Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects
Start: Nov 30, 2011
Completion: Oct 31, 2013